DK1048661T3 - Fremgangsmåde til fremstilling af anti-osteoporosemidler - Google Patents

Fremgangsmåde til fremstilling af anti-osteoporosemidler

Info

Publication number
DK1048661T3
DK1048661T3 DK00108504T DK00108504T DK1048661T3 DK 1048661 T3 DK1048661 T3 DK 1048661T3 DK 00108504 T DK00108504 T DK 00108504T DK 00108504 T DK00108504 T DK 00108504T DK 1048661 T3 DK1048661 T3 DK 1048661T3
Authority
DK
Denmark
Prior art keywords
preparation
osteoporosis agents
analogues
chem
novel
Prior art date
Application number
DK00108504T
Other languages
Danish (da)
English (en)
Inventor
Andrzej Robert Daniewski
Roumen Nikolaev Radinov
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1048661T3 publication Critical patent/DK1048661T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Epoxy Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
DK00108504T 1999-04-26 2000-04-19 Fremgangsmåde til fremstilling af anti-osteoporosemidler DK1048661T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13094899P 1999-04-26 1999-04-26

Publications (1)

Publication Number Publication Date
DK1048661T3 true DK1048661T3 (da) 2006-03-27

Family

ID=22447142

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00108504T DK1048661T3 (da) 1999-04-26 2000-04-19 Fremgangsmåde til fremstilling af anti-osteoporosemidler

Country Status (12)

Country Link
US (1) US6255501B1 (ja)
EP (1) EP1048661B1 (ja)
JP (1) JP2000336094A (ja)
KR (1) KR100697491B1 (ja)
CN (1) CN1272494A (ja)
AT (1) ATE311375T1 (ja)
CA (1) CA2306573C (ja)
DE (1) DE60024353T2 (ja)
DK (1) DK1048661T3 (ja)
ES (1) ES2251905T3 (ja)
JO (1) JO2176B1 (ja)
MX (1) MX221794B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH698144B1 (fr) * 2003-09-24 2009-05-29 Bioxell Spa Analogue de la vitamine D3
CA2476224A1 (en) 2003-09-24 2005-03-24 Bioxell Spa Compound and use in treatment
CA2619311A1 (en) * 2005-08-18 2007-02-22 Bioxell S.P.A. Synthesis of 1.alpha.-fluoro-25-hydroxy-16-23e-diene-26,27-bishomo-20-epi-cholecalciferol
US20100009949A1 (en) * 2006-03-24 2010-01-14 Bioxell S.P.A. Novel method
ES2366077B2 (es) * 2010-03-30 2012-06-25 Universidade De Vigo Compuestos quirales, procedimientos de obtención y uso.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG70009A1 (en) 1996-05-23 2000-01-25 Hoffmann La Roche Vitamin d3 analogs
US5872113A (en) * 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
US8830885B2 (en) * 2008-08-21 2014-09-09 Qualcomm Incorporated Multichannel architecture for high throughput modems

Also Published As

Publication number Publication date
JP2000336094A (ja) 2000-12-05
DE60024353D1 (de) 2006-01-05
KR100697491B1 (ko) 2007-03-20
KR20010014811A (ko) 2001-02-26
DE60024353T2 (de) 2006-08-03
ATE311375T1 (de) 2005-12-15
EP1048661B1 (en) 2005-11-30
CA2306573A1 (en) 2000-10-26
ES2251905T3 (es) 2006-05-16
JO2176B1 (en) 2003-04-23
EP1048661A2 (en) 2000-11-02
MXPA00003993A (es) 2002-03-08
MX221794B (es) 2004-07-27
CA2306573C (en) 2009-09-29
US6255501B1 (en) 2001-07-03
CN1272494A (zh) 2000-11-08
EP1048661A3 (en) 2002-10-09

Similar Documents

Publication Publication Date Title
ATE264295T1 (de) 7-substituierte kondensierte ring-tetrazyclin- verbindungen
FI922141A0 (fi) Analogiamenetelmä uusien hypoglykeemisten oksatsolidiinidionien valmistamiseksi
NO305080B1 (no) Baccatin-III-derivater
FI956270A0 (fi) Piperdiinijohdannaisia ja menetelmä niiden valmistamiseksi
HUP9802487A2 (hu) Intermedierek félszintetikus taxánokhoz és eljárás előállításukra
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
ATE179169T1 (de) Prostaglandinanaloge
DK0657411T3 (da) Forbedret syntese af bisindolylmaleimider
FI971227A (fi) Pyramidinyylipyratsolijohdannaisia
DK1048661T3 (da) Fremgangsmåde til fremstilling af anti-osteoporosemidler
DK0801054T3 (da) Fremgangsmåde til fremstilling af 2-(2-hydroxymethylphenyl)acetamidderivater og mellemprodukter til fremstilling deraf
DE69715417D1 (de) Oxazolidinester
DK0781764T3 (da) Fremgangsmåde til fremstilling af alkoxyiminoacetamid-derivater
NO20033049L (no) Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1-metylpiperidin
FI932691A (fi) Nya benzyl- och benzhydrylalkoholer
DE69102890D1 (de) Acyclische Terpene.
DK1219625T3 (da) Hidtil ukendte substituerede 2-(6-benzyl-5-oxo-3-phenyl-(S3,7S,7AR)-perhydroimidazol-(1,5-C)(1,3) thiazol-7YL)forbindelser
FI911124A0 (fi) Nya pyridinderivat och foerfaranden foer deras syntetisering.
EP1104424A4 (en) PROCESS FOR THE SYNTHESIS OF CARBAPENEM INTERMEDIATES AND COMPOUNDS PRODUCED
DK504788D0 (da) Fremgangsmaade til fremstilling af makrolidforbindelser
FI870098A0 (fi) Nya pregnanderivat, foerfaranden foer deras framstaellning och farmaceutiska preparat, vilka innehaoller desamma.